ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 30 announcements

Share price
₹480.00
Market cap
₹823.2 Cr
Revenue (annual)
₹46.57 Cr
Net profit (annual)
₹4.62 Cr
P/E (TTM)
178.2×Sector 43.8×
Promoter holding
72.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying (Off-Market) 4Other Announcement 3Fund Raise 3Financial Results 3Board Meeting Outcome 3Earnings Call 2Capital Structure Change 2Board Meeting Date 2Annual General Meeting 2Results Update 1Promoter Selling (Off-Market) 1Preferential Issue 1Credit Rating 1Capacity Expansion 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

1 announcement with these filters

20:06 IST BSE
Results Update

Aptus Pharma Results Update

Aptus Pharma Limited reported robust FY26 financial results, with total revenue doubling to ₹46.71 Crore and PAT increasing by 49% to ₹4.62 Crore. The company expanded its portfolio to over 250 formulations and services 25K+ retail outlets. Aptus aims for a pan-India presence by 2030 through its asset-light manufacturing model and strategic vertical expansion.

Open announcement → Read the filing ↗